Arthur Tzianabos - 01 Jan 2023 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Role
Director
Signature
/s/ W. Bradford Smith, Attorney-in-Fact for Arthur O. Tzianabos
Issuer symbol
QTTB
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 15:36:26 UTC
Previous filing
02 Dec 2022
Next filing
11 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIXX Common Stock Options Exercise +13,860 +16% 99,871 01 Jan 2023 Direct F1
transaction FIXX Common Stock Options Exercise +19,140 +19% 119,011 01 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Restricted Stock Units Options Exercise $0 -13,860 -49% $0.000000 14,280 01 Jan 2023 Common Stock 13,860 Direct F1, F2
transaction FIXX Restricted Stock Units Options Exercise $0 -19,140 -33% $0.000000 38,860 01 Jan 2023 Common Stock 19,140 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2 The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.
F3 The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.

Remarks:

Exhibit 24 - Power of Attorney